Cyclopropanes
-
Subject Areas on Research
- Anesthetic antagonism of the effects of high hydrostatic pressure on locomotory activity of the brine shrimp Artemia.
- Catalytic Enantio- and Diastereoselective Cyclopropanation of 2-Azadienes for the Synthesis of Aminocyclopropanes Bearing Quaternary Carbon Stereogenic Centers.
- Characterization and consequences of pain variability in individuals with fibromyalgia.
- Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran.
- Duloxetine: an emerging evidence for fibromyalgia.
- Efficacy of milnacipran in patients with fibromyalgia.
- Emerging treatment options to improve cardiovascular outcomes in patients with acute coronary syndrome: focus on losmapimod.
- Inactivation of the sodium current in squid giant axons by hydrocarbons.
- Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial.
- Mechanochemical strengthening of a synthetic polymer in response to typically destructive shear forces.
- Milnacipran: beyond a role of antidepressant.
- Modest increase in extracellular potassium unmasks effect of recurrent mossy fiber growth.
- Molecular stress relief through a force-induced irreversible extension in polymer contour length.
- Phase changes induced by cyclopropane of phosphatidylserine bilayers in the presence and absence of calcium.
- Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout Mice.
- Phosphodiesterase-4 inhibition restored hippocampal long term potentiation after primary blast.
- Reactive cross-talk between adjacent tension-trapped transition states.
- Stress-induced muscle and cutaneous hyperalgesia: differential effect of milnacipran.
- The study of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): design and rationale.